# MYMK

## Overview
The MYMK gene encodes the protein myomaker, a muscle-specific transmembrane protein that plays a pivotal role in the fusion of myoblasts, which are precursor cells that develop into muscle tissue. Myomaker is characterized by its seven transmembrane domains, which are essential for its function in facilitating the fusion of myoblasts into multinucleated myofibers, a critical process in muscle development and regeneration (Chen2019The). As a transmembrane protein, myomaker is involved in cell-cell interactions necessary for muscle fiber formation and repair. The expression of MYMK is tightly regulated by myogenic transcription factors, ensuring its activity is specific to muscle cells during myogenesis (Zhang2020Human). Dysfunction or mutations in the MYMK gene can lead to congenital myopathies, such as Carey-Fineman-Ziter syndrome, highlighting its clinical significance in muscle development and disease (Dugdale2024Aberrant).

## Structure
Myomaker (MYMK) is a muscle-specific transmembrane protein essential for myoblast fusion during muscle development and regeneration. The protein is embedded within the cell membrane and consists of seven transmembrane regions, each composed of 18-20 hydrophobic residues (Chen2019The). These transmembrane domains are crucial for its function in facilitating the fusion of myoblasts into multinucleated myofibers. The topology of Myomaker includes the N-terminal exposed extracellularly and the C-terminal intracellularly, which is typical for proteins involved in cell-cell interactions (Chen2019The).

The primary structure of Myomaker is encoded by the MYMK gene, and its secondary structure likely includes alpha helices, which are common in transmembrane proteins. The tertiary structure involves the folding of these helices into a functional conformation that spans the membrane. Although specific details about the quaternary structure are not provided, Myomaker's interaction with other proteins, such as Myomixer, suggests potential protein-protein interactions that are critical for its fusogenic activity (Chen2019The).

Post-translational modifications and splice variant isoforms of Myomaker have not been detailed in the available literature, indicating a need for further research to fully elucidate these aspects.

## Function
MYMK, also known as myomaker, is a muscle-specific membrane protein essential for myoblast fusion, a critical process in muscle development and regeneration. It facilitates the fusion of mononucleated myoblasts into multinucleated myotubes, which are necessary for the formation of muscle fibers (Zhang2020Human; Chen2019The). MYMK is active at the cell membrane, where it interacts with other proteins to mediate membrane fusion, impacting muscle growth and repair (Zhang2020Human).

MYMK's function is regulated by myogenic transcription factors such as MyoD and MyoG, which bind to its promoter region to ensure its expression is specific to muscle cells and appropriately timed during myogenesis (Zhang2020Human; Chen2019The). The presence of MYMK is crucial for the fusion process, as knockout studies have shown that the absence of MYMK results in a complete failure of myoblast fusion, preventing the formation of muscle syncytia (Zhang2020Human).

MYMK also plays a role in muscle hypertrophy and has potential therapeutic applications, such as promoting the fusion of non-muscle cells to muscle cells and restoring dystrophin expression in vitro (Chen2019The). Its activity is crucial for normal muscle development and maintenance, and its dysfunction can lead to congenital myopathies with cell-cell fusion deficits (Di2017A).

## Clinical Significance
Mutations in the MYMK gene, which encodes the protein myomaker, are associated with Carey-Fineman-Ziter syndrome (CFZS), a rare autosomal recessive congenital myopathy. CFZS is characterized by facial dysmorphisms, motor developmental delays, and distinct skeletal muscle symptoms, including generalized muscle weakness despite myofiber hypertrophy. This paradoxical condition arises from mutations that lead to increased myonuclei per muscle fiber but result in impaired myofiber contractility and altered energy mechanisms (Dugdale2024Aberrant). 

The mutations in MYMK can be either hypomorphic or null alleles, affecting the protein's stability and function, which is crucial for myoblast fusion during muscle development. These mutations result in defects in myoblast fusion, leading to muscle hypoplasia and hypotonia, as well as craniofacial abnormalities (Di2017A). 

In addition to CFZS, altered MYMK expression has implications in muscular dystrophies, such as Duchenne Muscular Dystrophy (DMD). While MYMK is essential for muscle regeneration, its expression in myofibers can exacerbate membrane instability and tissue damage, highlighting the need for regulated expression to balance muscle regeneration and membrane stability (Witcher2023Expression; Petrany2020Myocyte-derived).

## Interactions
MYMK (myomaker) is a muscle-specific membrane protein that plays a crucial role in myoblast fusion, a key process in muscle development and regeneration. MYMK interacts with MYMX (myomerger), another protein essential for myoblast fusion. While MYMK is involved in the mixing of membrane lipids, MYMX is necessary for fusion pore formation. These proteins work together to facilitate the fusion process, although MYMX can function independently of MYMK, suggesting that a direct physical interaction between the two is not required (Lehka2020Mechanisms).

MYMK's role in myoblast fusion is also linked to the actin cytoskeleton. Disruption of the cytoskeleton impairs MYMK-induced fusion, indicating a potential interaction with actin cytoskeleton regulators. The hyperfusion activity of a constitutively active form of Rac1, a small GTPase involved in actin dynamics, is dependent on MYMK activity, suggesting an interaction between MYMK and Rac1 (Si2018Genetic).

MYMK is regulated by myogenic factors such as MYOD and myogenin, which bind to E-box motifs on the MYMK promoter, driving its expression during muscle regeneration (Millay2014Myomaker). This regulation highlights the integration of MYMK within a network of proteins and pathways essential for muscle development and repair.


## References


[1. (Zhang2020Human) Haifeng Zhang, Junfei Wen, Anne Bigot, Jiacheng Chen, Renjie Shang, Vincent Mouly, and Pengpeng Bi. Human myotube formation is determined by myod–myomixer/myomaker axis. Science Advances, December 2020. URL: http://dx.doi.org/10.1126/sciadv.abc4062, doi:10.1126/sciadv.abc4062. This article has 61 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/sciadv.abc4062)

[2. (Witcher2023Expression) Phillip C. Witcher, Chengyi Sun, and Douglas P. Millay. Expression of myomaker and myomerger in myofibers causes muscle pathology. Skeletal Muscle, May 2023. URL: http://dx.doi.org/10.1186/s13395-023-00317-z, doi:10.1186/s13395-023-00317-z. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13395-023-00317-z)

[3. (Si2018Genetic) Yufeng Si, Haishen Wen, and Shaojun Du. Genetic mutations in jamb, jamc, and myomaker revealed different roles on myoblast fusion and muscle growth. Marine Biotechnology, 21(1):111–123, November 2018. URL: http://dx.doi.org/10.1007/s10126-018-9865-x, doi:10.1007/s10126-018-9865-x. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10126-018-9865-x)

[4. (Chen2019The) Bide Chen, Wenjing You, Yizhen Wang, and Tizhong Shan. The regulatory role of myomaker and myomixer–myomerger–minion in muscle development and regeneration. Cellular and Molecular Life Sciences, 77(8):1551–1569, October 2019. URL: http://dx.doi.org/10.1007/s00018-019-03341-9, doi:10.1007/s00018-019-03341-9. This article has 50 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-019-03341-9)

[5. (Di2017A) Silvio Alessandro Di Gioia, Samantha Connors, Norisada Matsunami, Jessica Cannavino, Matthew F. Rose, Nicole M. Gilette, Pietro Artoni, Nara Lygia de Macena Sobreira, Wai-Man Chan, Bryn D. Webb, Caroline D. Robson, Long Cheng, Carol Van Ryzin, Andres Ramirez-Martinez, Payam Mohassel, Mark Leppert, Mary Beth Scholand, Christopher Grunseich, Carlos R. Ferreira, Tyler Hartman, Ian M. Hayes, Tim Morgan, David M. Markie, Michela Fagiolini, Amy Swift, Peter S. Chines, Carlos E. Speck-Martins, Francis S. Collins, Ethylin Wang Jabs, Carsten G. Bönnemann, Eric N. Olson, Caroline V. Andrews, Brenda J. Barry, David G. Hunter, Sarah E. Mackinnon, Sherin Shaaban, Monica Erazo, Tamiesha Frempong, Ke Hao, Thomas P. Naidich, Janet C. Rucker, Zhongyang Zhang, Barbara B. Biesecker, Lori L. Bonnycastle, Carmen C. Brewer, Brian P. Brooks, John A. Butman, Wade W. Chien, Kathleen Farrell, Edmond J. FitzGibbon, Andrea L. Gropman, Elizabeth B. Hutchinson, Minal S. Jain, Kelly A. King, Tanya J. Lehky, Janice Lee, Denise K. Liberton, Narisu Narisu, Scott M. Paul, Neda Sadeghi, Joseph Snow, Beth Solomon, Angela Summers, Camilo Toro, Audrey Thurm, Christopher K. Zalewski, John C. Carey, Stephen P. Robertson, Irini Manoli, and Elizabeth C. Engle. A defect in myoblast fusion underlies carey-fineman-ziter syndrome. Nature Communications, July 2017. URL: http://dx.doi.org/10.1038/ncomms16077, doi:10.1038/ncomms16077. This article has 75 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms16077)

[6. (Lehka2020Mechanisms) Lilya Lehka and Maria Jolanta Rędowicz. Mechanisms regulating myoblast fusion: a multilevel interplay. Seminars in Cell &amp; Developmental Biology, 104:81–92, August 2020. URL: http://dx.doi.org/10.1016/j.semcdb.2020.02.004, doi:10.1016/j.semcdb.2020.02.004. This article has 84 citations.](https://doi.org/10.1016/j.semcdb.2020.02.004)

[7. (Dugdale2024Aberrant) Hannah F. Dugdale, Yotam Levy, Heinz Jungbluth, Anders Oldfors, and Julien Ochala. Aberrant myonuclear domains and impaired myofiber contractility despite marked hypertrophy in mymk-related, carey-fineman-ziter syndrome. Acta Neuropathologica Communications, May 2024. URL: http://dx.doi.org/10.1186/s40478-024-01783-2, doi:10.1186/s40478-024-01783-2. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40478-024-01783-2)

[8. (Petrany2020Myocyte-derived) Michael J. Petrany, Taejeong Song, Sakthivel Sadayappan, and Douglas P. Millay. Myocyte-derived myomaker expression is required for regenerative fusion but exacerbates membrane instability in dystrophic myofibers. JCI Insight, May 2020. URL: http://dx.doi.org/10.1172/jci.insight.136095, doi:10.1172/jci.insight.136095. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1172/jci.insight.136095)

[9. (Millay2014Myomaker) Douglas P. Millay, Lillian B. Sutherland, Rhonda Bassel-Duby, and Eric N. Olson. Myomaker is essential for muscle regeneration. Genes &amp; Development, 28(15):1641–1646, August 2014. URL: http://dx.doi.org/10.1101/gad.247205.114, doi:10.1101/gad.247205.114. This article has 148 citations.](https://doi.org/10.1101/gad.247205.114)